HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significance of renal hyaline arteriolosclerosis and tubulo-interstitial change in IgA glomerulonephropathy and focal glomerular sclerosis.

Abstract
The relationship between glomerular sclerosis and hyaline arteriolosclerosis (HA) or tubulo-interstitial (T-I) change was investigated in 66 patients with IgA glomerulonephropathy (IgA-GN) and in 12 patients with idiopathic focal segmental glomerulosclerosis (FGS). More than a 10% incidence of global sclerosis was noted in 15 patients with IgA-GN and in 9 patients with FGS. There was no significant discrepancy of age between patients with IgA-GN and those with FGS (IgA-GN: 37.5 +/- 12.5; FGS: 35.7 +/- 10.3). In patients with IgA-GN, 7 out of 15 were HA-positive (46.7%), whereas in patients with FGS, 7 out of 9 were HA-positive (77.8%). However, a close correlation was observed between glomerular sclerosis and T-I change only in patients with IgA-GN (r = 0.82; p less than 0.001). The results suggested that in the case of IgA-GN, T-I change was related to the prognosis of glomerular sclerosis. In addition, it is assumed that a possible correlation exists between FGS and HA.
AuthorsO Hotta, N Yoshizawa, S Oshima, A Takeuchi, O Kawamura, S Kondo, T Kubota, H Niwa
JournalNephron (Nephron) Vol. 47 Issue 4 Pg. 262-5 ( 1987) ISSN: 1660-8151 [Print] Switzerland
PMID3696327 (Publication Type: Journal Article)
Chemical References
  • Creatinine
Topics
  • Adolescent
  • Adult
  • Aged
  • Arteriosclerosis (complications, pathology)
  • Creatinine (blood)
  • Female
  • Glomerulonephritis (complications)
  • Glomerulonephritis, IGA (complications, pathology)
  • Glomerulosclerosis, Focal Segmental (complications, pathology)
  • Humans
  • Male
  • Middle Aged
  • Nephritis, Interstitial (complications, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: